Gum Bacteria and Alzheimer's: The New Drug Target

When a pharmaceutical company spends millions developing a drug that targets bacteria from your mouth — inside the brain — it tells you something about where the science has landed. We’ve covered how oral bacteria reach your brain through two distinct pathways and what the latest research says about the oral-brain connection. But the story doesn’t stop at understanding the mechanism. Researchers are now actively trying to treat Alzheimer’s disease by blocking the toxic enzymes that gum disease bacteria produce in brain tissue. Whether or not the drug works, the fact that it exists changes the conversation about what Alzheimer’s actually is — and what you should be doing about your gums right now.

What’s actually happening

In 2019, a team led by Stephen Dominy published a landmark study in Science Advances that shifted the oral-brain conversation from “interesting association” to “potential causation” (Dominy et al., 2019). The researchers examined postmortem brain tissue from Alzheimer’s patients and found Porphyromonas gingivalis — the keystone pathogen behind chronic periodontal disease — in the majority of samples. They also found its toxic proteases, called gingipains, and here’s the part that changed everything: the levels of those gingipains correlated directly with tau pathology and amyloid accumulation. More gingipains meant worse Alzheimer’s markers.

This wasn’t a vague statistical association. The bacteria were in the brain. Their toxic enzymes were in the brain. And the amount of enzyme tracked with the severity of the disease.

The researchers then infected mice with P. gingivalis through the mouth — mimicking human gum disease — and watched what happened over time. The oral infection led to brain colonization, increased amyloid-beta production, neuroinflammation, and hippocampal neuron damage. The hippocampus is the brain region critical for memory consolidation and one of the first areas to degenerate in Alzheimer’s disease.

Then came the part that got pharmaceutical attention: when the researchers treated the infected mice with small-molecule inhibitors designed to block gingipain activity, they saw reduced bacterial load in the brain, decreased amyloid production, reduced neuroinflammation, and rescued hippocampal neurons. Block the toxin, protect the brain.

Why a pharmaceutical company cares

Cortexyme — now called Gwynedd Therapeutics — was founded on this exact premise. Their lead compound, atuzaginstat (COR388), is a gingipain inhibitor designed to cross the blood-brain barrier and block the toxic proteases that P. gingivalis produces once it reaches brain tissue.

The drug entered Phase II/III clinical trials for mild to moderate Alzheimer’s disease — a significant investment in the idea that targeting oral bacteria could treat neurodegeneration. A 2020 study published in Pharmacology Research & Perspectives tested a related compound (COR388) in aged dogs naturally infected with P. gulae, the canine equivalent of P. gingivalis. The treatment reduced bacterial infection, decreased neuroinflammation markers, and improved cognitive function in the animals.

This matters beyond the specific drug. When a pharmaceutical company bets on a mechanism, it means the preclinical evidence was strong enough to justify hundreds of millions in development costs. The gingipain hypothesis — that P. gingivalis toxins drive neurodegeneration and blocking them can slow or reverse it — passed that bar.

The two pathways that make this plausible

You might wonder: how do bacteria from your gums end up in your brain in the first place? The research identifies two distinct routes, and understanding both explains why the connection is so consistent across studies.

The first is direct bloodstream invasion. When gum tissue is chronically inflamed and ulcerated, the capillary bed beneath it becomes permeable. P. gingivalis produces outer membrane vesicles — tiny structures that carry its virulence factors, including gingipains, and are small enough to cross the blood-brain barrier. A 2023 review in Critical Reviews in Microbiology documented how these vesicles trigger neuroinflammation, disrupt the brain’s ion regulation, and accelerate amyloid plaque and tau tangle accumulation once they cross into brain tissue.

The second route runs through the gut. When you swallow, you’re swallowing your oral microbial community. In the presence of gum disease, that community contains a disproportionate share of pathogenic species. A 2025 study in the Journal of Dental Research found that P. gingivalis colonization causes significant gut microbiome dysbiosis, disrupts intestinal barrier integrity, and alters kynurenine metabolism — a pathway that directly regulates neuroinflammation and neuronal survival. The disrupted kynurenine pathway produces elevated levels of a neurotoxic metabolite that suppresses neuroprotective genes and triggers cell death in the brain. The bacteria don’t even need to cross the blood-brain barrier directly. They disrupt your gut, your gut disrupts a critical metabolic pathway, and the disrupted pathway contributes to neurodegeneration.

Why this is happening to you specifically

Gum disease affects roughly half of adults over 35 in the United States. By your 60s and 70s, that number climbs to 70 to 80 percent with significant disease — not just surface inflammation, but actual bone loss. And periodontal disease is largely painless in its early stages. Bleeding gums get normalized. People rinse, spit, and move on.

The problem is that this silent infection has been active for years — possibly decades — before anyone connects it to cognitive changes. If you’re in your 40s or 50s and noticing brain fog or memory that feels less sharp, the standard conversation focuses on stress, sleep, or hormones. Those are valid. But the inflammatory burden from chronic periodontal disease might be part of the picture, and it’s the part almost nobody checks.

What you can do today

These actions map directly to the mechanisms researchers have identified.

1. Get a periodontal evaluation — not just a routine cleaning. Ask specifically about pocket depth measurements and any signs of bone loss. A standard dental cleaning doesn’t assess these. If you’re over 40 and haven’t had periodontal charting, request one.

2. Take bleeding gums seriously. Bleeding when you brush or floss isn’t normal — it’s an active inflammatory process. That inflammation is the entry point for bacteria to reach your bloodstream. See a periodontist if your general dentist flags concerns.

3. Floss with purpose. The goal isn’t removing food particles. It’s disrupting the bacterial biofilm below the gumline where P. gingivalis thrives. Wrap the floss in a C-shape around each tooth and slide it gently beneath the gumline.

4. Reduce your total inflammatory burden. Everything that reduces systemic inflammation also reduces your susceptibility to periodontal disease and its downstream effects. A diet rich in diverse plant fibers, fermented foods, and anti-inflammatory fats creates a better bacterial environment throughout your digestive tract — including your mouth.

5. Address gut and oral health together. The bidirectional relationship between oral and gut health means treating one without the other leaves the job half done. Gut dysbiosis can worsen oral health, and oral dysbiosis can worsen gut health. Support both.

The supplement question

Probiotics designed for oral health — distinct from gut probiotics — are an emerging area. The research is still developing, but targeted strains that colonize the mouth may help rebalance the oral microbiome. This is not a substitute for periodontal treatment if you have active disease, but it’s worth discussing with a practitioner who understands the oral-brain connection.

For gut microbiome support — which directly affects the oral-gut-brain axis — a quality synbiotic (probiotic plus prebiotic) is a practical starting point. Seed DS-01 Daily Synbiotic combines 24 clinically studied strains with a prebiotic outer capsule designed to survive stomach acid and deliver bacteria to the colon, where they can influence systemic inflammation through the gut-brain axis.

Omega-3 fatty acids have documented anti-inflammatory effects that support neurological health and may help modulate the inflammatory cascade triggered by periodontal infection. Nordic Naturals Ultimate Omega provides high-potency EPA and DHA — the two omega-3s most directly linked to reduced neuroinflammation. A 2024 review in Frontiers in Immunology confirmed that the immune pathways driving periodontal inflammation are the same ones implicated in systemic chronic disease, and anti-inflammatory interventions that target those pathways are relevant regardless of where the inflammation originates.

If you want to support both gut barrier integrity and microbial diversity, Butyrate Gummies with Probiotic and Prebiotic combine butyrate — a short-chain fatty acid critical for gut lining repair — with probiotics and omega-3. Butyrate is particularly relevant here because gut dysbiosis triggered by oral bacteria disrupts the metabolic pathways that produce it, and restoring butyrate levels supports the intestinal barrier that oral pathogens exploit.

What we still don’t know

The gingipain inhibitor trials are still underway, and we don’t yet have definitive results showing that blocking these enzymes in humans slows Alzheimer’s progression. The preclinical evidence is strong — mouse models, canine models, and brain tissue studies all point the same direction — but clinical trial outcomes are what ultimately matter. If atuzaginstat or a similar compound succeeds, it would fundamentally reshape how we think about Alzheimer’s as a disease with an infectious component. If it doesn’t, the underlying science about oral bacteria in the brain still stands — it just means blocking one enzyme isn’t enough.

Either way, the research has moved past the question of whether oral bacteria can reach the brain. They can. The question now is what that means for prevention — and whether you’re going to wait for a drug or start with your gums.

Save for later — send this to someone who keeps ignoring their bleeding gums.